Heba H Mostafa Selected Research

Intraabdominal Infections

1/2022

Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heba H Mostafa Research Topics

Disease

26	Infections 10/2022 - 12/2011
13	COVID-19 10/2022 - 11/2020
4	Breakthrough Infections 07/2022 - 09/2021
2	Fever (Fevers) 06/2021 - 03/2021
2	Human Influenza (Influenza) 01/2021 - 02/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2016
1	Reinfection 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Eye Diseases (Eye Disease) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Intraabdominal Infections 01/2022
1	Asymptomatic Infections 07/2021
1	Respiratory Syncytial Virus Infections 01/2021
1	Paramyxoviridae Infections (Parainfluenza) 01/2018
1	Latent Infection 01/2018

Drug/Important Bio-Agent (IBA)

8	Viral RNAIBA 01/2022 - 01/2021
5	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2020
5	Immunoglobulin G (IgG)IBA 01/2022 - 07/2021
5	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2013
5	VaccinesIBA 01/2022 - 01/2018
5	AntibodiesIBA 01/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2018
3	COVID-19 VaccinesIBA 07/2022 - 09/2021
2	AntigensIBA 01/2022 - 03/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 07/2021
1	casirivimab and imdevimab drug combinationIBA 06/2022
1	remdesivirIBA 06/2022
1	mRNA VaccinesIBA 01/2022
1	CefiderocolIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Nucleic AcidsIBA 01/2021
1	SolutionsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2018
1	LuciferasesIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Chemokine CCL5IBA 12/2017
1	Oseltamivir (Tamiflu)FDA Link 12/2017
1	CytokinesIBA 12/2017
1	Neuraminidase (Sialidase)IBA 01/2017
1	peramivirIBA 01/2017
1	Surface Antigens (Surface Antigen)IBA 02/2016
1	Hemagglutinins (Hemagglutinin)IBA 02/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 05/2015
1	Ubiquitin-Specific ProteasesIBA 05/2014
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2014
1	Biological ProductsIBA 12/2011

Therapy/Procedure

5	Therapeutics 06/2022 - 01/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018